摘要
目的在根除幽门螺旋杆菌治疗过程中应用左氧氟沙星三联治疗,并评价其临床效果。方法采取自愿原则在我院2015年5月~2016年4月收治的感染幽门螺旋杆菌患者中随机选取48例,并依据计算机表法将所有患者均分为观察组与对照组,每组24例患者。在治疗对照组患者时应用常规三联疗法,在治疗观察组患者时应用左氧氟沙星三联治疗,将两组患者行不同疗法治疗后的临床疗效进行对比分析。结果经对应方法治疗后,观察组患者的根除率、不良反应发生率显著更优,与对照组进行组间数据对比,差异有统计学意义,P〈0.05。结论在根除幽门螺旋杆菌治疗过程中应用左氧氟沙星三联治疗的临床疗效较为确切,根除率较高,不良反应发生几率较低。
Objective To applications in the eradication of helicobacter pylori treatment process levofloxacin triple therapy, and evaluate its clinical effect. Methods 48 cases of Helicobacter pylori infection were selected in our hospital from May 2015 to April 2016, and according to the computer table, all patients were divided into observation group and control group, 24 cases in each group. In the treatment of patients in the control group, the use of conventional triple therapy, in the treatment of patients in the observation group were treated with levofloxacin triple therapy, the two groups of patients with different therapy after the treatment of the clinical efficacy of comparative analysis. Results After corresponding treatment, the eradication rate and adverse reaction rate of the observation group were significantly better than that of the control group, the difference was statistically significant, P〈0.05. Conclusion In the treatment of Helicobacter pylori eradication in the treatment process, the clinical efficacy of levofloxacin triple therapy is more accurate, higher eradication rate, the incidence of adverse reactions is lower.
出处
《中国继续医学教育》
2016年第33期178-179,共2页
China Continuing Medical Education
关键词
幽门螺旋杆菌
左氧氟沙星三联治疗
临床疗效
根除
Helicobacter pylori
Levofloxacin triple therapy
Clinical efficacy
Eradication
